Christopher J. McCabe

4.3k total citations
90 papers, 3.0k citations indexed

About

Christopher J. McCabe is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research. According to data from OpenAlex, Christopher J. McCabe has authored 90 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Endocrinology, Diabetes and Metabolism, 28 papers in Molecular Biology and 19 papers in Cancer Research. Recurrent topics in Christopher J. McCabe's work include Pituitary Gland Disorders and Treatments (23 papers), Thyroid Disorders and Treatments (21 papers) and Thyroid Cancer Diagnosis and Treatment (19 papers). Christopher J. McCabe is often cited by papers focused on Pituitary Gland Disorders and Treatments (23 papers), Thyroid Disorders and Treatments (21 papers) and Thyroid Cancer Diagnosis and Treatment (19 papers). Christopher J. McCabe collaborates with scholars based in United Kingdom, United States and Italy. Christopher J. McCabe's co-authors include J. A. Franklyn, Kristien Boelaert, Mark D. Kilby, Neil Gittoes, Vicki E. Smith, Shiao‐Yng Chan, Jayne A. Franklyn, Lesley Tannahill, John Watkinson and Anna L. Stratford and has published in prestigious journals such as Nucleic Acids Research, Circulation and The Journal of Immunology.

In The Last Decade

Christopher J. McCabe

88 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. McCabe United Kingdom	34	1.5k	848	478	475	329	90	3.0k
Kristien Boelaert United Kingdom	33	3.4k 2.2×	768 0.9×	251 0.5×	394 0.8×	392 1.2×	86	4.1k
Geneviève Plu‐Bureau France	34	1.7k 1.1×	340 0.4×	356 0.7×	164 0.3×	1.3k 3.9×	120	3.9k
R G Rosenfeld United States	28	2.0k 1.3×	1.1k 1.3×	229 0.5×	493 1.0×	535 1.6×	56	2.6k
Diane Brisson Canada	34	1.0k 0.7×	1.6k 1.9×	849 1.8×	489 1.0×	787 2.4×	115	4.3k
Annekatrin Lukanova Sweden	28	1.2k 0.8×	1.8k 2.1×	241 0.5×	1.2k 2.4×	623 1.9×	49	4.6k
Terence R.J. Lappin United Kingdom	37	244 0.2×	1.4k 1.7×	455 1.0×	1.2k 2.5×	700 2.1×	105	4.0k
Yuji Hiramatsu Japan	32	270 0.2×	618 0.7×	756 1.6×	234 0.5×	337 1.0×	136	3.2k
M Ferdeghini Italy	34	1.3k 0.8×	467 0.6×	73 0.2×	214 0.5×	183 0.6×	153	3.2k
Mary Anne Rossing United States	22	305 0.2×	489 0.6×	118 0.2×	535 1.1×	617 1.9×	32	2.5k
V. Kerlan France	18	786 0.5×	277 0.3×	125 0.3×	186 0.4×	450 1.4×	90	1.6k

Countries citing papers authored by Christopher J. McCabe

Since Specialization

Citations

This map shows the geographic impact of Christopher J. McCabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. McCabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. McCabe more than expected).

Fields of papers citing papers by Christopher J. McCabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. McCabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. McCabe. The network helps show where Christopher J. McCabe may publish in the future.

Co-authorship network of co-authors of Christopher J. McCabe

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. McCabe. A scholar is included among the top collaborators of Christopher J. McCabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. McCabe. Christopher J. McCabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stein, Robert C., A. Marshall, Luke Hughes‐Davies, et al.. (2025). 190O Clinical outcomes in the OPTIMA prelim (Optimal Personalised Treatment of early breast cancer using Multi-Parameter Analysis) feasibility study. ESMO Open. 10. 104744–104744. 1 indexed citations

Read, Martin L., Selvambigai Manivannan, Jana Kim, et al.. (2023). Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo. Clinical Cancer Research. 30(7). 1352–1366. 8 indexed citations

Ramírez-Moya, Julia, León Wert-Lamas, Alice Fletcher, et al.. (2022). Identification of an interactome network between lncRNAs and miRNAs in thyroid cancer reveals SPTY2D1-AS1 as a new tumor suppressor. Scientific Reports. 12(1). 7706–7706. 5 indexed citations

Okosieme, Onyebuchi, Jackie Gilbert, Kristien Boelaert, et al.. (2021). Thyrotoxicosis and hyperthyroidism: causes, diagnosis and management. Pharmaceutical journal/The pharmaceutical journal.

Fletcher, Alice, Martin L. Read, Dean P. Larner, et al.. (2019). Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake. Cancer Research. 80(1). 102–115. 34 indexed citations

Thompson, Rebecca, Alice Fletcher, Mohammed Merae Alshahrani, et al.. (2019). Dimerization of the Sodium/Iodide Symporter. Thyroid. 29(10). 1485–1498. 9 indexed citations

Read, Martin L., Jim C. Fong, Anne Fletcher, et al.. (2017). Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. Oncogene. 36(37). 5296–5308. 21 indexed citations

Watkins, Rachel, Martin L. Read, Neil Sharma, et al.. (2016). Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin. The Journal of Clinical Endocrinology & Metabolism. 101(12). 4551–4563. 10 indexed citations

Madsen, Kathrine Skak, William F.C. Baaré, Natacha Akshoomoff, et al.. (2012). Common repeat polymorphism in the dopamine transporter gene SLC6A3 is associated with stop signal reaction time (SSRT) and motion coherence threshold (MCT). Research at the University of Copenhagen (University of Copenhagen). 1 indexed citations

10.

Read, Martin L., Neil Sharma, Robert Seed, et al.. (2011). Proto-oncogene PBF/PTTG1IP Regulates Thyroid Cell Growth and Represses Radioiodide Treatment. Cancer Research. 71(19). 6153–6164. 40 indexed citations

11.

Smith, Vicki E., Jayne A. Franklyn, & Christopher J. McCabe. (2011). Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptake. Journal of Endocrinology. 210(2). 157–163. 23 indexed citations

12.

Thorne, James L., Orla Maguire, Craig Doig, et al.. (2010). Epigenetic control of a VDR-governed feed-forward loop that regulates p21 ( waf1/cip1 ) expression and function in non-malignant prostate cells. Nucleic Acids Research. 39(6). 2045–2056. 55 indexed citations

13.

Mania‐Farnell, Barbara, Shunsuke Ichi, Christopher J. McCabe, et al.. (2008). Key basic helix–loop–helix transcription factor genes Hes1 and Ngn2 are regulated by Pax3 during mouse embryonic development. Developmental Biology. 316(2). 510–523. 59 indexed citations

14.

Boelaert, Kristien, Vicki E. Smith, Anna L. Stratford, et al.. (2007). PTTG and PBF repress the human sodium iodide symporter. Oncogene. 26(30). 4344–4356. 46 indexed citations

15.

Connock, Martin, Amanda Burls, Emma Frew, et al.. (2006). The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review. Health Technology Assessment. 10(24). iii–iv, ix. 69 indexed citations

16.

Khanim, Farhat L., Christopher J. McCabe, J. N. Bulmer, et al.. (2004). The effects of thyroid hormone on cytokine-induced proliferation in human trophoblast cells. 7. 1 indexed citations

17.

McCabe, Christopher J., Kristien Boelaert, Anthony P. Heaney, et al.. (2003). Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor‐2 (FGF‐2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clinical Endocrinology. 58(2). 141–150. 125 indexed citations

18.

Tannahill, Lesley, T. J. Visser, Christopher J. McCabe, et al.. (2002). Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumours. Clinical Endocrinology. 56(6). 735–743. 39 indexed citations

19.

McCabe, Christopher J.. (2001). Genetic targets for the treatment of pituitary adenomas: focus on the pituitary tumor transforming gene. Current Opinion in Pharmacology. 1(6). 620–625. 7 indexed citations

20.

Pharoah, P O, et al.. (1996). Cost of care for a geographically determined population of low birthweight infants to age 8-9 years. II. Children with disability.. Archives of Disease in Childhood Fetal & Neonatal. 74(2). F118–F121. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact